gpx glutathione transferase Optimal DX Hot Topics: Support Frontiers | Glutathione S-Transferases: Role

doi: 10.3390/biom12040542

Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention

Capek J, Hauschke M, Bruckova L, Rousar T (2017) Comparison of glutathione levels measured using optimized monochlorobimane assay with those from ortho-phthalaldehyde assay in intact cells

Hes at UT Southwestern in Dallas

Pseudomonas aeruginosa in bronchiectasis

In cancer cells, increased ROS will oxidize the specific isoform of pyruvate kinase (PKM2), diverting glucose flux towards the PPP and generation of NADPH for GSH recycling